Recombinant adeno-associated virus (rAAV) is a leading viral vector modality for gene therapy, with several approved treatments and hundreds of ongoing clinical trials. rAAV manufacturing, while ...
The limiting factor in the development of local gene therapies for ISR is the lack of a safe and efficient vector system to transduce vascular cells within the arterial wall. 2 The optimal delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback